AGP Limited (PSX:AGP)
150.90
+0.75 (0.50%)
At close: Sep 17, 2026
AGP Limited Revenue
AGP Limited had revenue of 4.68B PKR in the quarter ending June 30, 2026, a decrease of -15.87%. This brings the company's revenue in the last twelve months to 27.70B, up 6.09% year-over-year. In the year 2025, AGP Limited had annual revenue of 28.89B with 15.40% growth.
Revenue (ttm)
27.70B
Revenue Growth
+6.09%
P/S Ratio
1.52
Revenue / Employee
12.92M
Employees
2,143
Market Cap
42.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.89B | 3.86B | 15.40% |
| Dec 31, 2024 | 25.03B | 6.29B | 33.56% |
| Dec 31, 2023 | 18.74B | 4.28B | 29.63% |
| Dec 31, 2022 | 14.46B | 5.14B | 55.19% |
| Dec 31, 2021 | 9.32B | 2.37B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.02B |
| GlaxoSmithKline Pakistan | 67.12B |
| The Searle Company | 35.99B |
| Highnoon Laboratories | 28.50B |
| Ferozsons Laboratories | 22.68B |
| Citi Pharma | 13.84B |
| Macter International | 11.95B |
| Otsuka Pakistan | 4.11B |